Post #3969121

STUDY: "SARS-CoV-2 infection confers substantially greater and more sustained cardiovascular risk than BNT162b2 vaccination… consistent with a favorable cardiovascular risk-benefit profile for vaccination. SARS-CoV-2 infection was associated with 3- to 5-fold increases in cardiovascular events during the acute phase… with risks persisting beyond nine months. BNT162b2 vaccination conferred 65-76% reductions in major adverse cardiovascular events." #COVID19 https://www.nature.com/articles/s41541-026-01528-3